Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Sugammadex reverses the effects of steroidal neuromuscular blocking agents rapidly and completely. Unlike neostigmine, its antagonism is long lasting, has no ceiling effect, and minimizes the risk of residual neuromuscular block. These unique pharmacologic properties may influence not only the emergence from anesthesia but also induction and tracheal intubation strategies across perioperative settings, including critical care, emergency medicine, and prehospital resuscitation, especially in the context of difficult airway management. However, the full impact of sugammadex on airway management has been underappreciated. As a reversal agent for difficult airways, it remains underutilized, largely due to limited awareness of its unique properties. This narrative review synthesizes the current literature, highlights practical considerations in daily airway management, and examines the potential paradigm shift introduced by sugammadex while also outlining future directions for research.

More information Original publication

DOI

10.1097/ALN.0000000000005828

Type

Journal article

Publication Date

2026-04-01T00:00:00+00:00

Volume

144

Pages

978 - 997

Total pages

19

Keywords

Sugammadex, Humans, Airway Management, Neuromuscular Blockade, Intubation, Intratracheal, Neuromuscular Nondepolarizing Agents